|
|
Zeile 9: |
Zeile 9: |
| | colspan=2 bgcolor="#F6F3EE"|''VaccineType'' | | | colspan=2 bgcolor="#F6F3EE"|''VaccineType'' |
| | bgcolor="#F6F3EE"|2.16.840.1.113883.5.145 | | | bgcolor="#F6F3EE"|2.16.840.1.113883.5.145 |
− | | bgcolor="#F6F3EE"|2012-07-24 | + | | bgcolor="#F6F3EE"|2012-07-24T00:00:00 |
| | bgcolor="#F6F3EE"|definitiv | | | bgcolor="#F6F3EE"|definitiv |
| |- | | |- |
Zeile 17: |
Zeile 17: |
| | bgcolor="#ECE9E4" colspan="2"|'''Beschreibung''' | | | bgcolor="#ECE9E4" colspan="2"|'''Beschreibung''' |
| |- | | |- |
− | |-
| |
− | |0-L
| |
− | |'''54'''
| |
− | |<font color="grey">(en-US)</font> adenovirus, type 4
| |
− | | colspan="2" |<p>adenovirus vaccine, type 4, live, oral</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''55'''
| |
− | |<font color="grey">(en-US)</font> adenovirus, type 7
| |
− | | colspan="2" |<p>adenovirus vaccine, type 7, live, oral</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''82'''
| |
− | |<font color="grey">(en-US)</font> adenovirus, NOS
| |
− | | colspan="2" |<p>adenovirus vaccine, NOS</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''24'''
| |
− | |<font color="grey">(en-US)</font> Anthrax
| |
− | | colspan="2" |<p>anthrax vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''19'''
| |
− | |<font color="grey">(en-US)</font> BCG
| |
− | | colspan="2" |<p>Bacillus Calmette-Guerin vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''27'''
| |
− | |<font color="grey">(en-US)</font> botulinum antitoxin
| |
− | | colspan="2" |<p>botulinum antitoxin</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''26'''
| |
− | |<font color="grey">(en-US)</font> Cholera
| |
− | | colspan="2" |<p>cholera vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''29'''
| |
− | |<font color="grey">(en-US)</font> CMVIG
| |
− | | colspan="2" |<p>cytomegalovirus immune globulin, intravenous</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''56'''
| |
− | |<font color="grey">(en-US)</font> dengue fever
| |
− | | colspan="2" |<p>dengue fever vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''12'''
| |
− | |<font color="grey">(en-US)</font> diphtheria antitoxin
| |
− | | colspan="2" |<p>diphtheria antitoxin</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''28'''
| |
− | |<font color="grey">(en-US)</font> DT (pediatric)
| |
− | | colspan="2" |<p>diphtheria and tetanus toxoids, adsorbed for pediatric use</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''20'''
| |
− | |<font color="grey">(en-US)</font> DTaP
| |
− | | colspan="2" |<p>diphtheria, tetanus toxoids and acellular pertussis vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''50'''
| |
− | |<font color="grey">(en-US)</font> DTaPHib
| |
− | | colspan="2" |<p>DTaP-Haemophilus influenzae type b conjugate vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''1'''
| |
− | |<font color="grey">(en-US)</font> DTP
| |
− | | colspan="2" |<p>diphtheria, tetanus toxoids and pertussis vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''22'''
| |
− | |<font color="grey">(en-US)</font> DTP-Hib
| |
− | | colspan="2" |<p>DTP-Haemophilus influenzae type b conjugate vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''57'''
| |
− | |<font color="grey">(en-US)</font> Hantavirus
| |
− | | colspan="2" |<p>hantavirus vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''52'''
| |
− | |<font color="grey">(en-US)</font> Hep A, adult
| |
− | | colspan="2" |<p>hepatitis A vaccine, adult dosage</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''83'''
| |
− | |<font color="grey">(en-US)</font> Hep A, ped/adol, 2 dose
| |
− | | colspan="2" |<p>hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''84'''
| |
− | |<font color="grey">(en-US)</font> Hep A, ped/adol, 3 dose
| |
− | | colspan="2" |<p>hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''31'''
| |
− | |<font color="grey">(en-US)</font> Hep A, pediatric, NOS
| |
− | | colspan="2" |<p>hepatitis A vaccine, pediatric dosage, NOS</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''85'''
| |
− | |<font color="grey">(en-US)</font> Hep A, NOS
| |
− | | colspan="2" |<p>hepatitis A vaccine, NOS</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''30'''
| |
− | |<font color="grey">(en-US)</font> HBIG
| |
− | | colspan="2" |<p>hepatitis B immune globulin</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''8'''
| |
− | |<font color="grey">(en-US)</font> Hep B, adolescent or pediatric
| |
− | | colspan="2" |<p>hepatitis B vaccine, pediatric or pediatric/adolescent dosage</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''42'''
| |
− | |<font color="grey">(en-US)</font> Hep B, adolescent/high risk infant
| |
− | | colspan="2" |<p>hepatitis B vaccine, adolescent/high risk infant dosage</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''43'''
| |
− | |<font color="grey">(en-US)</font> Hep B, adult
| |
− | | colspan="2" |<p>hepatitis B vaccine, adult dosage</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''44'''
| |
− | |<font color="grey">(en-US)</font> Hep B, dialysis
| |
− | | colspan="2" |<p>hepatitis B vaccine, dialysis patient dosage</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''45'''
| |
− | |<font color="grey">(en-US)</font> Hep B, NOS
| |
− | | colspan="2" |<p>hepatitis B vaccine, NOS</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''58'''
| |
− | |<font color="grey">(en-US)</font> Hep C
| |
− | | colspan="2" |<p>hepatitis C vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''59'''
| |
− | |<font color="grey">(en-US)</font> Hep E
| |
− | | colspan="2" |<p>hepatitis E vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''60'''
| |
− | |<font color="grey">(en-US)</font> herpes simplex 2
| |
− | | colspan="2" |<p>herpes simplex virus, type 2 vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''46'''
| |
− | |<font color="grey">(en-US)</font> Hib (PRP-D)
| |
− | | colspan="2" |<p>Haemophilus influenzae type b vaccine, PRP-D conjugate</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''47'''
| |
− | |<font color="grey">(en-US)</font> Hib (HbOC)
| |
− | | colspan="2" |<p>Haemophilus influenzae type b vaccine, HbOC conjugate</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''48'''
| |
− | |<font color="grey">(en-US)</font> Hib (PRP-T)
| |
− | | colspan="2" |<p>Haemophilus influenzae type b vaccine, PRP-T conjugate</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''49'''
| |
− | |<font color="grey">(en-US)</font> Hib (PRP-OMP)
| |
− | | colspan="2" |<p>Haemophilus influenzae type b vaccine, PRP-OMP conjugate</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''17'''
| |
− | |<font color="grey">(en-US)</font> Hib, NOS
| |
− | | colspan="2" |<p>Haemophilus influenzae type b vaccine, conjugate NOS</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''51'''
| |
− | |<font color="grey">(en-US)</font> Hib-Hep B
| |
− | | colspan="2" |<p>Haemophilus influenzae type b conjugate and Hepatitis B vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''61'''
| |
− | |<font color="grey">(en-US)</font> HIV
| |
− | | colspan="2" |<p>human immunodeficiency virus vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''62'''
| |
− | |<font color="grey">(en-US)</font> HPV
| |
− | | colspan="2" |<p>human papilloma virus vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''86'''
| |
− | |<font color="grey">(en-US)</font> IG
| |
− | | colspan="2" |<p>immune globulin, intramuscular</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''87'''
| |
− | |<font color="grey">(en-US)</font> IGIV
| |
− | | colspan="2" |<p>immune globulin, intravenous</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''14'''
| |
− | |<font color="grey">(en-US)</font> IG, NOS
| |
− | | colspan="2" |<p>immune globulin, NOS</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''15'''
| |
− | |<font color="grey">(en-US)</font> influenza, split (incl. purified surface antigen)
| |
− | | colspan="2" |<p>influenza virus vaccine, split virus (incl. purified surface antigen)</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''16'''
| |
− | |<font color="grey">(en-US)</font> influenza, whole
| |
− | | colspan="2" |<p>influenza virus vaccine, whole virus</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''88'''
| |
− | |<font color="grey">(en-US)</font> influenza, NOS
| |
− | | colspan="2" |<p>influenza virus vaccine, NOS</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''10'''
| |
− | |<font color="grey">(en-US)</font> IPV
| |
− | | colspan="2" |<p>poliovirus vaccine, inactivated</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''2'''
| |
− | |<font color="grey">(en-US)</font> OPV
| |
− | | colspan="2" |<p>poliovirus vaccine, live, oral</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''89'''
| |
− | |<font color="grey">(en-US)</font> polio, NOS
| |
− | | colspan="2" |<p>poliovirus vaccine, NOS</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''39'''
| |
− | |<font color="grey">(en-US)</font> Japanese encephalitis
| |
− | | colspan="2" |<p>Japanese encephalitis vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''63'''
| |
− | |<font color="grey">(en-US)</font> Junin virus
| |
− | | colspan="2" |<p>Junin virus vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''64'''
| |
− | |<font color="grey">(en-US)</font> leishmaniasis
| |
− | | colspan="2" |<p>leishmaniasis vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''65'''
| |
− | |<font color="grey">(en-US)</font> leprosy
| |
− | | colspan="2" |<p>leprosy vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''66'''
| |
− | |<font color="grey">(en-US)</font> Lyme disease
| |
− | | colspan="2" |<p>Lyme disease vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''3'''
| |
− | |<font color="grey">(en-US)</font> MMR
| |
− | | colspan="2" |<p>measles, mumps and rubella virus vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''4'''
| |
− | |<font color="grey">(en-US)</font> M/R
| |
− | | colspan="2" |<p>measles and rubella virus vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''94'''
| |
− | |<font color="grey">(en-US)</font> MMRV
| |
− | | colspan="2" |<p>measles, mumps, rubella, and varicella virus vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''67'''
| |
− | |<font color="grey">(en-US)</font> malaria
| |
− | | colspan="2" |<p>malaria vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''5'''
| |
− | |<font color="grey">(en-US)</font> measles
| |
− | | colspan="2" |<p>measles virus vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''68'''
| |
− | |<font color="grey">(en-US)</font> melanoma
| |
− | | colspan="2" |<p>melanoma vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''32'''
| |
− | |<font color="grey">(en-US)</font> meningococcal
| |
− | | colspan="2" |<p>meningococcal polysaccharide vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''7'''
| |
− | |<font color="grey">(en-US)</font> mumps
| |
− | | colspan="2" |<p>mumps virus vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''69'''
| |
− | |<font color="grey">(en-US)</font> parainfluenza-3
| |
− | | colspan="2" |<p>parainfluenza-3 virus vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''11'''
| |
− | |<font color="grey">(en-US)</font> pertussis
| |
− | | colspan="2" |<p>pertussis vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''23'''
| |
− | |<font color="grey">(en-US)</font> plague
| |
− | | colspan="2" |<p>plague vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''33'''
| |
− | |<font color="grey">(en-US)</font> pneumococcal
| |
− | | colspan="2" |<p>pneumococcal polysaccharide vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''100'''
| |
− | |<font color="grey">(en-US)</font> pneumococcal conjugate
| |
− | | colspan="2" |<p>pneumococcal conjugate vaccine, polyvalent</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''70'''
| |
− | |<font color="grey">(en-US)</font> Q fever
| |
− | | colspan="2" |<p>Q fever vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''18'''
| |
− | |<font color="grey">(en-US)</font> rabies, intramuscular injection
| |
− | | colspan="2" |<p>rabies vaccine, for intramuscular injection</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''40'''
| |
− | |<font color="grey">(en-US)</font> rabies, intradermal injection
| |
− | | colspan="2" |<p>rabies vaccine, for intradermal injection</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''90'''
| |
− | |<font color="grey">(en-US)</font> rabies, NOS
| |
− | | colspan="2" |<p>rabies vaccine, NOS</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''72'''
| |
− | |<font color="grey">(en-US)</font> rheumatic fever
| |
− | | colspan="2" |<p>rheumatic fever vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''73'''
| |
− | |<font color="grey">(en-US)</font> Rift Valley fever
| |
− | | colspan="2" |<p>Rift Valley fever vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''34'''
| |
− | |<font color="grey">(en-US)</font> RIG
| |
− | | colspan="2" |<p>rabies immune globulin</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''74'''
| |
− | |<font color="grey">(en-US)</font> rotavirus
| |
− | | colspan="2" |<p>rotavirus vaccine, tetravalent, live, oral</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''71'''
| |
− | |<font color="grey">(en-US)</font> RSV-IGIV
| |
− | | colspan="2" |<p>respiratory syncytial virus immune globulin, intravenous</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''93'''
| |
− | |<font color="grey">(en-US)</font> RSV-Mab
| |
− | | colspan="2" |<p>respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''6'''
| |
− | |<font color="grey">(en-US)</font> rubella
| |
− | | colspan="2" |<p>rubella virus vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''38'''
| |
− | |<font color="grey">(en-US)</font> rubella/mumps
| |
− | | colspan="2" |<p>rubella and mumps virus vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''75'''
| |
− | |<font color="grey">(en-US)</font> smallpox
| |
− | | colspan="2" |<p>smallpox vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''76'''
| |
− | |<font color="grey">(en-US)</font> Staphylococcus bacterio lysate
| |
− | | colspan="2" |<p>Staphylococcus bacteriophage lysate</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''9'''
| |
− | |<font color="grey">(en-US)</font> Td (adult)
| |
− | | colspan="2" |<p>tetanus and diphtheria toxoids, adsorbed for adult use</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''35'''
| |
− | |<font color="grey">(en-US)</font> tetanus toxoid
| |
− | | colspan="2" |<p>tetanus toxoid</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''77'''
| |
− | |<font color="grey">(en-US)</font> tick-borne encephalitis
| |
− | | colspan="2" |<p>tick-borne encephalitis vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''13'''
| |
− | |<font color="grey">(en-US)</font> TIG
| |
− | | colspan="2" |<p>tetanus immune globulin</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''95'''
| |
− | |<font color="grey">(en-US)</font> TST-OT tine test
| |
− | | colspan="2" |<p>tuberculin skin test; old tuberculin, multipuncture device</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''96'''
| |
− | |<font color="grey">(en-US)</font> TST-PPD intradermal
| |
− | | colspan="2" |<p>tuberculin skin test; purified protein derivative solution, intradermal</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''97'''
| |
− | |<font color="grey">(en-US)</font> TST-PPD tine test
| |
− | | colspan="2" |<p>tuberculin skin test; purified protein derivative, multipuncture device</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''98'''
| |
− | |<font color="grey">(en-US)</font> TST, NOS
| |
− | | colspan="2" |<p>tuberculin skin test; NOS</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''78'''
| |
− | |<font color="grey">(en-US)</font> tularemia vaccine
| |
− | | colspan="2" |<p>tularemia vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''25'''
| |
− | |<font color="grey">(en-US)</font> typhoid, oral
| |
− | | colspan="2" |<p>typhoid vaccine, live, oral</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''41'''
| |
− | |<font color="grey">(en-US)</font> typhoid, parenteral
| |
− | | colspan="2" |<p>typhoid vaccine, parenteral, other than acetone-killed, dried</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''53'''
| |
− | |<font color="grey">(en-US)</font> typhoid, parenteral, AKD (U.S. military)
| |
− | | colspan="2" |<p>typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''101'''
| |
− | |<font color="grey">(en-US)</font> typhoid, ViCPs
| |
− | | colspan="2" |<p>Typhoid Vi capsular polysaccharide vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''91'''
| |
− | |<font color="grey">(en-US)</font> typhoid, NOS
| |
− | | colspan="2" |<p>typhoid vaccine, NOS</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''79'''
| |
− | |<font color="grey">(en-US)</font> vaccinia immune globulin
| |
− | | colspan="2" |<p>vaccinia immune globulin</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''21'''
| |
− | |<font color="grey">(en-US)</font> varicella
| |
− | | colspan="2" |<p>varicella virus vaccine</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''81'''
| |
− | |<font color="grey">(en-US)</font> VEE, inactivated
| |
− | | colspan="2" |<p>Venezuelan equine encephalitis, inactivated</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''80'''
| |
− | |<font color="grey">(en-US)</font> VEE, live
| |
− | | colspan="2" |<p>Venezuelan equine encephalitis, live, attenuated</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''92'''
| |
− | |<font color="grey">(en-US)</font> VEE, NOS
| |
− | | colspan="2" |<p>Venezuelan equine encephalitis vaccine, NOS</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''36'''
| |
− | |<font color="grey">(en-US)</font> VZIG
| |
− | | colspan="2" |<p>varicella zoster immune globulin</p>
| |
− | |-
| |
− | |0-L
| |
− | |'''37'''
| |
− | |<font color="grey">(en-US)</font> yellow fever
| |
− | | colspan="2" |<p>yellow fever vaccine</p>
| |
| |} | | |} |